FBIO
Fortress Biotech Inc
2.00$
-1.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -48.3% | -175.1% | -194.8% | -146.6% | -137.1% | -85.4% | -148.9% | -167.9% | -34.7% | -78.0% | 1,271.1% | -316.7% | 183.9% | |
| 7.9% | 8.6% | 9.1% | 8.0% | 22.7% | -8.2% | 12.8% | 7.0% | 6.6% | 7.2% | 10.6% | 5.7% | 7.4% | |
| 12.6% | 18.6% | 37.3% | 33.6% | 44.9% | 107.1% | 47.9% | 102.3% | 18.1% | 15.3% | 10.9% | 15.4% | 15.0% | |
| -23.8% | -91.0% | 43.5% | -21.4% | -38.1% | -37.9% | -22.7% | -41.3% | -25.7% | -67.2% | 347.8% | -286.6% | -19.3% | |
| 2.9% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | 0.1% | |
| 14.4% | -0.3% | – | – | – | -99.2% | 8.9% | 37.1% | 16.3% | 45.1% | – | -0.4% | – | |
| 6.3% | 11.0% | 16.8% | 14.7% | 1.2% | 1.1% | 1.3% | 1.0% | 0.9% | 1.0% | 0.0% | 0.8% | 0.7% | |
| 0.3% | -2.0% | 0.0% | -17.6% | 0.0% | – | -1.1% | -0.7% | 0.0% | 0.0% | -89.4% | 0.0% | -20.9% | |
| – | – | – | – | -118.5% | 33.1% | 0.0% | -30.0% | -4.0% | 0.0% | -90.4% | 0.0% | -22.2% | |
| -7.7% | 218.7% | 213.8% | 95.8% | 18.5% | 170.7% | 396.8% | 27.5% | 85.5% | 35.5% | -170.8% | 0.5% | -9.5% | |
| -41.6% | 31.0% | 19.0% | -50.8% | -118.6% | -13.9% | 256.8% | -103.3% | 67.1% | -42.5% | 1,100.3% | -316.6% | 178.5% | |
| -51.2% | -175.5% | -194.8% | -146.6% | -137.1% | -85.4% | -148.9% | -167.9% | -34.7% | -78.0% | 1,271.1% | -317.1% | 183.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.